— Know what they know.
Not Investment Advice
Also trades as: 0HI3.L (LSE) · $vol 0M

ARWR NASDAQ

Arrowhead Pharmaceuticals, Inc.
1W: +0.2% 1M: -9.8% 3M: -31.5% YTD: -12.9% 1Y: +55.3% 3Y: +132.0% 5Y: -12.0%
$59.03
+0.05 (+0.08%)
 
Weekly Expected Move ±4.7%
$53 $55 $58 $61 $63
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $8.3B mcap · 122M float · 1.74% daily turnover · Short 56% of daily vol
Credit Risk of going bust: higher than 52% of companies Debt: 9.4% of company value Bonds: $79.9M held by 47 funds → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.78 (down 99%), Arrowhead Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $864.1M against a stock market value of $8.34B.
Distance to default 4.96 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $452.0M (short-term plus half of long-term), stock volatility 60.3%; Altman Z'' 1.13. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
40.3 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: 65.7%
Cost Advantage
47
Intangibles
51
Switching Cost
40
Network Effect
27
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ARWR shows a Weak competitive edge (40.3/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. ROIC of 65.7% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$74
Low
$101
Avg Target
$120
High
Based on 5 analysts since Aug 4, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 16Hold: 6Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$101.40
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-14 UBS Joon Lee $110 $109 -1 +86.7% $58.37
2026-09-24 Goldman Sachs Andrea Newkirk $31 $74 +43 +10.5% $66.96
2026-08-31 RBC Capital Luca Issi $80 $100 +20 +21.5% $82.32
2026-08-06 H.C. Wainwright — $115 $120 +5 +40.2% $85.61
2026-08-05 Stifel Nicolaus — $98 $104 +6 +16.1% $89.59
2026-07-27 H.C. Wainwright — $100 $115 +15 +34.3% $85.60
2026-07-23 Morgan Stanley — $100 $120 +20 +35.8% $88.38
2026-07-23 Piper Sandler Edward Tenthoff $110 $126 +16 +42.1% $88.70
2026-07-22 Chardan Capital Keay Nakae $90 $115 +25 +26.3% $91.03
2026-07-13 Stifel Nicolaus James Condulis Initiated $98 — +32.2% $74.11
2026-05-13 Bernstein — $35 $46 +11 -41.8% $79.04
2026-05-08 Chardan Capital — $80 $90 +10 +15.5% $77.95
2026-04-21 Morgan Stanley — $78 $100 +22 +44.4% $69.25
2026-02-06 Morgan Stanley — $81 $78 -3 +17.1% $66.64
2026-01-27 Robert W. Baird — Initiated $81 — +20.9% $67.02
2026-01-21 H.C. Wainwright — $85 $100 +15 +45.3% $68.80
2026-01-13 UBS — Initiated $110 — +61.7% $68.03
2026-01-13 Piper Sandler — $100 $110 +10 +66.8% $65.93
2026-01-07 Morgan Stanley — $48 $81 +33 +14.4% $70.81
2026-01-07 Chardan Capital — Initiated $80 — +13.0% $70.81
2026-01-02 Tudor Pickering William Pickering Initiated $35 — -47.3% $66.39
2025-12-31 Bernstein — $24 $35 +11 -48.0% $67.25
2025-12-17 Piper Sandler Edward Tenthoff $52 $100 +48 +54.7% $64.66
2025-12-11 RBC Capital — $50 $80 +30 +16.1% $68.91
2025-12-02 H.C. Wainwright — $60 $85 +25 +51.1% $56.25
2025-11-26 Morgan Stanley — $37 $48 +11 +2.6% $46.79
2024-11-29 Bernstein William Pickering Initiated $24 — -7.0% $25.81
2024-11-27 Loop Capital Markets Keay Nakae Initiated $60 — +365.1% $12.90
2024-09-03 Citigroup David Lebowitz Initiated $27 — +17.9% $22.91
2024-07-05 H.C. Wainwright Patrick Trucchio $90 $60 -30 +369.9% $12.77
2024-06-04 Goldman Sachs Andrea Tan $85 $31 -54 +22.6% $25.29
2024-05-30 RBC Capital Luca Issi $77 $50 -27 +337.4% $11.43
2023-02-07 RBC Capital — Initiated $77 — +368.1% $16.45
2023-02-07 Piper Sandler — Initiated $52 — +55.2% $33.51
2022-12-06 H.C. Wainwright — Initiated $90 — +471.4% $15.75
2022-11-29 Jefferies — Initiated $75 — +400.3% $14.99
2022-11-29 Morgan Stanley — Initiated $37 — +32.1% $28.00
2022-11-28 Leerink Partners — Initiated $31 — +10.7% $28.00
2022-01-18 Goldman Sachs Madhu Kumar Initiated $85 — +58.0% $53.79

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
Oct 27, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ARWR receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-08 B- D+
2026-02-06 D+ B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 35 Grade D
Profitability
20
Balance Sheet
43
Earnings Quality
51
Growth
42
Value
40
Momentum
42
Safety
90
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ARWR scores highest in Safety (90/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.84
Safe Zone
Piotroski F-Score
4/9
✗ ✗ ✗ ✓ ✓ ✓ ✗ ✓ ✗
Beneish M-Score
-2.13
Unlikely Manipulator
Ohlson O-Score
-5.39
Bankruptcy prob: 0.5%
Low Risk
Credit Rating
BBB
Score: 56.0/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.18x
Accruals: -14.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ARWR scores 3.84, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ARWR scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ARWR's score of -2.13 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ARWR's implied 0.5% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ARWR receives an estimated rating of BBB (score: 56.0/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-26.35x
PEG
0.00x
P/S
12.45x
P/B
18.18x
P/FCF
-155.59x
P/OCF
—
EV/EBITDA
-81.91x
EV/Revenue
16.35x
EV/EBIT
-68.66x
EV/FCF
-145.77x
Earnings Yield
-2.74%
FCF Yield
-0.64%
Shareholder Yield
0.33%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ARWR currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.269
NI / EBT
×
Interest Burden
1.581
EBT / EBIT
×
EBIT Margin
-0.238
EBIT / Rev
×
Asset Turnover
0.383
Rev / Assets
×
Equity Multiplier
3.536
Assets / Equity
=
ROE
-64.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ARWR's ROE of -64.8% is driven by financial leverage (equity multiplier: 3.54x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.27 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$59.03
Median 1Y
$50.96
5th Pctile
$16.58
95th Pctile
$158.21
Ann. Volatility
66.5%
Analyst Target
$101.40
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Christopher Anzalone
President and Chief Executive Officer
$981,046 $6,810,292 $9,029,861
Patrick O’Brien Operating
rating Officer
$653,940 $1,979,000 $3,030,195
James Hamilton Medical
edical Officer
$617,512 $1,979,000 $2,966,213
Kenneth Myszkowski Financial
ief Financial Officer
$496,783 $1,979,000 $2,660,161
Daniel Apel Financial
ancial Officer
$232,212 $1,287,000 $1,754,912
Tracie Oliver Commercial
ef Commercial Officer
$43,193 $— $43,193

CEO Pay Ratio

52:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $9,029,861
Avg Employee Cost (SGA/emp): $174,322
Employees: 711

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
711
+16.8% YoY
Revenue / Employee
$1,166,594
Rev: $829,448,000
Profit / Employee
$-2,294
NI: $-1,631,000
SGA / Employee
$174,322
Avg labor cost proxy
R&D / Employee
$853,951
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
ROE -32.4% -44.3% -24.9% -34.6% -43.6% -41.2% -33.4% -44.2% -61.3% -1.1% -1.0% -1.5% -2.6% -6.0% -24.7% -34.8% -0.5% 65.1% -46.4% -64.8% -64.78%
ROA -22.9% -32.2% -15.3% -20.7% -25.1% -20.2% -18.8% -23.4% -28.2% -39.1% -51.0% -64.1% -62.9% -78.0% -11.4% -13.1% -0.1% 15.5% -15.7% -18.3% -18.32%
ROIC -1.8% -2.2% -1.2% -1.1% -1.4% 2.9% -2.5% 34.5% -64.5% -71.2% -1.0% -1.2% -1.3% -1.3% -28.7% -25.4% -61.9% -7.7% -86.3% 65.7% 65.68%
ROCE -26.4% -37.5% -20.5% -25.0% -31.6% -19.6% -17.7% -23.2% -28.5% -50.2% -51.1% -66.8% -56.0% -65.2% -6.6% -6.3% 11.8% 27.5% -8.1% -8.7% -8.72%
Gross Margin 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 76.0% 1.0% — — 42.5% 1.0% 1.0% 77.6% 1.0% 1.0% 1.0% 1.0% 1.00%
Operating Margin -1.7% -2.3% 27.4% -2.2% -2.7% -67.4% 32.9% -6.5% -6.7% -38.5% — — -6.9% -64.6% 70.2% -6.0% 17.2% 15.5% -1.9% -2.3% -2.26%
Net Margin -1.7% -2.3% 29.2% -2.2% -2.7% -66.1% 33.3% -6.5% -6.8% -37.4% — — -7.2% -69.2% 68.3% -6.3% -9.3% 11.7% -1.8% -2.6% -2.58%
EBITDA Margin -1.6% -2.2% 30.9% -2.1% -2.6% -58.0% 37.9% -6.0% -6.2% -36.3% — — -6.5% -59.3% 73.2% -5.3% 25.0% 21.7% -1.5% -2.0% -1.96%
FCF Margin 1.1% 85.7% -28.5% -48.0% -77.7% -84.9% -1.3% -1.3% -1.4% -2.2% -13.3% -27.1% -22.3% -21.9% 1.7% -3.0% 18.9% 29.5% -8.2% -11.2% -11.22%
OCF Margin 1.2% 1.0% -19.9% -36.6% -56.0% -54.0% -89.7% -77.0% -63.9% -1.1% -7.2% -17.9% -17.1% -18.8% 10.8% 3.7% 21.6% 31.1% -5.8% -8.8% -8.82%
ROE 3Y Avg snapshot only -86.70%
ROE 5Y Avg snapshot only -68.73%
ROA 3Y Avg snapshot only -28.95%
ROIC Economic snapshot only -13.59%
Cash ROA snapshot only -2.80%
NOPAT Margin snapshot only -26.72%
Pretax Margin snapshot only -37.65%
R&D / Revenue snapshot only 1.08%
SGA / Revenue snapshot only 25.55%
SBC / Revenue snapshot only 10.46%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
P/E Ratio -46.33 -37.87 -44.40 -24.19 -19.85 -27.83 -18.29 -21.07 -14.05 -11.07 -7.49 -5.99 -3.94 -3.67 -11.90 -14.80 -2869.63 46.18 -29.67 -36.53 -26.353
P/S Ratio 47.19 47.99 18.84 14.90 14.37 15.45 10.07 14.89 11.98 18.09 99.40 164.29 87.07 89.97 3.01 3.68 5.64 8.56 14.36 17.46 12.454
P/B Ratio 15.96 18.60 10.98 8.20 8.77 11.41 6.15 10.46 10.63 20.49 7.29 9.77 12.74 44.63 2.51 4.21 10.04 16.43 14.54 25.10 18.181
P/FCF 44.20 56.02 -66.18 -31.07 -18.50 -18.21 -7.78 -11.13 -8.72 -8.16 -7.50 -6.07 -3.91 -4.11 178.55 -124.67 29.83 29.01 -175.53 -155.59 -155.593
P/OCF 38.11 46.58 — — — — — — — — — — — — 28.02 100.56 26.07 27.53 — — —
EV/EBITDA -43.93 -36.95 -43.26 -23.27 -19.47 -27.74 -17.86 -21.96 -16.30 -12.88 -7.75 -6.39 -4.51 -4.59 -19.91 -38.28 25.04 23.60 -63.35 -81.91 -81.911
EV/Revenue 44.72 45.88 17.41 13.56 13.16 13.94 8.61 13.45 11.89 19.03 95.92 165.18 93.37 102.20 2.38 3.37 4.98 8.01 13.70 16.35 16.354
EV/EBIT -41.49 -35.19 -39.65 -21.74 -18.31 -25.80 -16.53 -20.48 -15.22 -12.24 -7.48 -6.17 -4.37 -4.44 -15.20 -26.77 29.29 25.32 -53.30 -68.66 -68.657
EV/FCF 41.88 53.55 -61.16 -28.27 -16.94 -16.43 -6.65 -10.05 -8.66 -8.59 -7.24 -6.10 -4.19 -4.66 141.35 -114.05 26.31 27.13 -167.45 -145.77 -145.769
Earnings Yield -2.2% -2.6% -2.3% -4.1% -5.0% -3.6% -5.5% -4.7% -7.1% -9.0% -13.4% -16.7% -25.4% -27.3% -8.4% -6.8% -0.0% 2.2% -3.4% -2.7% -2.74%
FCF Yield 2.3% 1.8% -1.5% -3.2% -5.4% -5.5% -12.9% -9.0% -11.5% -12.3% -13.3% -16.5% -25.6% -24.4% 0.6% -0.8% 3.4% 3.4% -0.6% -0.6% -0.64%
PEG Ratio snapshot only 0.002
Price/Tangible Book snapshot only 25.409
EV/Gross Profit snapshot only 16.354
Shareholder Yield snapshot only 0.33%
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Current Ratio 2.62 2.47 3.01 3.37 2.92 4.11 6.60 6.69 3.98 3.73 8.31 4.65 6.74 6.09 5.15 4.87 4.86 3.38 6.23 5.90 5.899
Quick Ratio 2.59 2.43 2.96 3.32 3.07 4.64 6.60 6.55 3.98 3.73 8.31 4.65 6.74 6.09 5.15 4.87 4.86 3.38 6.23 5.90 5.899
Debt/Equity 0.06 0.07 0.06 0.18 0.20 0.22 0.19 0.23 1.41 2.45 0.83 1.37 4.59 16.58 1.08 1.37 0.79 0.55 2.24 1.86 1.856
Net Debt/Equity -0.84 -0.82 -0.83 -0.74 -0.74 -1.11 -0.89 -1.01 -0.07 1.07 -0.25 0.05 0.92 6.07 -0.52 -0.36 -1.19 -1.06 -0.67 -1.59 -1.585
Debt/Assets 0.04 0.04 0.04 0.11 0.12 0.09 0.09 0.10 0.50 0.63 0.42 0.51 0.75 0.86 0.47 0.52 0.26 0.19 0.61 0.41 0.409
Debt/EBITDA -0.18 -0.14 -0.24 -0.56 -0.50 -0.59 -0.63 -0.53 -2.18 -1.46 -0.91 -0.89 -1.52 -1.50 -10.87 -13.59 2.22 0.84 -10.21 -6.46 -6.464
Net Debt/EBITDA 2.43 1.70 3.55 2.30 1.79 3.00 3.03 2.35 0.11 -0.64 0.28 -0.03 -0.30 -0.55 5.24 3.56 -3.36 -1.63 3.06 5.52 5.520
Interest Coverage — — — — — -52.81 -17.97 -12.88 -10.27 -13.56 -19.76 -22.89 -17.93 -12.34 -1.42 -0.91 1.58 3.83 -1.73 -1.72 -1.722
Equity Multiplier 1.74 1.71 1.56 1.66 1.74 2.36 1.99 2.18 2.82 3.90 1.97 2.67 6.15 19.28 2.30 2.64 2.97 2.82 3.69 4.54 4.537
Cash Ratio snapshot only 5.654
Debt Service Coverage snapshot only -1.443
Cash to Debt snapshot only 1.854
FCF to Debt snapshot only -0.087
Defensive Interval snapshot only 656.1 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Asset Turnover 0.22 0.25 0.36 0.34 0.35 0.36 0.34 0.33 0.33 0.24 0.04 0.02 0.03 0.03 0.45 0.53 0.66 0.83 0.32 0.38 0.383
Inventory Turnover 32.11 23.54 39.73 35.61 — — 82.39 30.48 — — — 2.62 — — — — — — — — —
Receivables Turnover 24.92 31.56 231.88 549.32 41.70 14.02 7.71 344.84 341.47 9.19 1.02 31.51 — 20.87 481.01 123.02 243.10 9.86 68.92 73.35 73.349
Payables Turnover 16.98 32.47 33.13 31.38 39.47 114.45 27.06 37.22 11.80 63.15 2.68 0.76 0.97 2.42 1.98 0.66 0.43 0.26 0.31 0.00 —
DSO 15 12 2 1 9 26 47 1 1 40 357 12 0 17 1 3 2 37 5 5 5.0 days
DIO 11 16 9 10 -13 -39 4 12 -17 -71 0 139 0 0 0 0 0 0 0 — —
DPO 21 11 11 12 9 3 13 10 31 6 136 477 377 151 184 550 852 1390 1194 — —
Cash Conversion Cycle 5 16 -0 -1 -13 -16 38 3 -47 -37 221 -326 -377 -133 -183 -547 -851 -1353 -1189 — —
Fixed Asset Turnover snapshot only 1.561
Cash Velocity snapshot only 0.418
Capital Intensity snapshot only 3.155
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 57.2% 80.9% 2.0% 1.3% 75.9% 92.7% 3.6% 2.5% -1.0% -34.7% -87.0% -92.3% -88.7% -85.6% 15.0% 29.4% 29.6% 40.8% 9.4% 12.2% 12.22%
Net Income -66.6% -78.3% -2.0% -22.3% -25.0% 15.6% -34.3% -17.7% -16.6% -92.1% -2.1% -2.0% -1.9% -1.2% 69.4% 72.4% 99.7% 1.3% -1.1% -1.2% -1.16%
EPS -63.7% -75.3% 1.8% -20.3% -23.6% 16.8% -34.1% -16.3% -14.9% -89.6% -1.7% -1.6% -1.6% -85.4% 72.0% 75.4% 99.8% 1.3% -97.4% -1.1% -1.09%
FCF 2.4% 2.0% -1.5% -1.7% -2.3% -2.9% -3.7% -1.9% -75.0% -70.5% -33.1% -55.2% -82.8% -41.9% 1.0% 96.7% 1.3% 1.6% -6.3% -3.3% -3.26%
EBITDA -61.4% -69.4% 4.7% -14.9% -16.8% 22.0% -24.0% -7.8% -6.8% -91.9% -2.3% -2.2% -2.2% -1.2% 84.5% 89.7% 1.3% 1.6% -97.4% -1.5% -1.55%
Op. Income -60.0% -67.6% -0.1% -18.8% -19.8% 16.5% -27.2% -13.1% -14.8% -90.3% -2.1% -2.0% -1.9% -1.1% 75.0% 80.3% 1.2% 1.5% -87.2% -1.1% -1.10%
OCF Growth snapshot only -3.70%
Asset Growth snapshot only 52.98%
Equity Growth snapshot only -10.87%
Debt Growth snapshot only 21.14%
Shares Change snapshot only 3.12%
Growth (CAGR)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 3Y 1.0% 45.1% 40.6% 22.3% 12.9% 19.4% 25.2% 27.5% 39.9% 31.5% -26.4% -43.3% -41.9% -43.5% 29.3% 33.6% 50.5% 57.7% 31.6% 37.7% 37.74%
Revenue 5Y 2.9% 1.0% 81.4% 61.5% 50.6% 55.6% 65.1% 79.9% 71.7% 30.9% -17.8% -32.2% -30.6% -30.7% 32.6% 37.0% 56.6% 68.7% 47.5% 44.1% 44.13%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — -2.6% — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — 3.1% — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 85.3% 23.3% 28.2% 30.7% 25.5% 14.9% 16.7% 12.7% 13.6% 7.8% 8.1% 6.3% 17.1% 16.7% 30.8% 22.5% 26.0% 21.6% 36.5% 38.4% 38.45%
Assets 5Y 40.8% 34.7% 40.9% 45.6% 46.1% 58.8% 47.7% 47.8% 47.0% 12.9% 23.4% 21.3% 26.6% 11.5% 22.9% 20.0% 21.5% 26.3% 24.5% 23.5% 23.51%
Equity 3Y 62.2% 29.4% 31.0% 26.1% 17.7% -9.0% -3.3% -9.6% -16.2% -29.3% 2.8% -8.9% -23.2% -47.9% 14.7% 4.8% 5.4% 14.7% 11.2% 8.5% 8.46%
Book Value 3Y 57.4% 25.6% 26.9% 23.3% 14.4% -11.6% -5.3% -11.0% -17.4% -30.4% -2.9% -14.1% -27.0% -50.9% 6.6% -4.3% -3.0% 4.3% 1.4% -1.6% -1.62%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue Stability 0.57 0.60 0.72 0.72 0.64 0.66 0.82 0.89 0.94 0.66 0.02 0.01 0.07 0.12 0.24 0.25 0.36 0.36 0.59 0.57 0.569
Earnings Stability 0.06 0.20 0.20 0.38 0.48 0.54 0.64 0.68 0.69 0.79 0.76 0.81 0.80 0.84 0.39 0.33 0.06 0.00 0.26 0.19 0.192
Margin Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.91 0.90 0.94 0.86 0.93 0.93 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.20 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend -0.39 -0.43 -0.13 -0.17 -0.18 -0.05 -0.09 -0.18 -0.36 -1.40 -0.68 -1.21 -2.63 -11.03 0.44 0.78 1.99 7.36 0.10 0.27 0.270
Gross Margin Trend 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.09 0.32 0.33 0.13 0.08 0.81 0.80 0.89 0.89 0.35 0.35 0.352
FCF Margin Trend 1.20 1.73 -1.05 -0.90 -0.70 -0.51 -2.08 -1.88 -1.52 -2.22 -12.46 -26.17 -21.19 -20.38 7.29 14.18 12.01 12.36 6.54 13.44 13.440
Sustainable Growth Rate — — — — — — — — — — — — — — — — — 65.1% — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — 18.3% — — —
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
OCF/Net Income -1.22 -0.81 0.47 0.59 0.77 0.97 1.63 1.09 0.75 0.66 0.55 0.65 0.77 0.77 -0.42 -0.15 -110.09 1.68 0.12 0.18 0.185
FCF/OCF 0.86 0.83 1.43 1.31 1.39 1.57 1.44 1.74 2.15 2.05 1.83 1.52 1.31 1.16 0.16 -0.81 0.87 0.95 1.40 1.27 1.272
FCF/Net Income snapshot only 0.235
CapEx/Revenue 17.0% 17.4% 8.6% 11.3% 21.7% 30.9% 39.8% 56.8% 73.4% 1.1% 6.0% 9.2% 5.2% 3.1% 9.1% 6.6% 2.7% 1.6% 2.3% 2.4% 2.40%
CapEx/Depreciation snapshot only 0.622
Accruals Ratio -0.51 -0.58 -0.08 -0.08 -0.06 -0.01 0.12 0.02 -0.07 -0.13 -0.23 -0.22 -0.14 -0.18 -0.16 -0.15 -0.14 -0.10 -0.14 -0.15 -0.149
Sloan Accruals snapshot only 0.349
Cash Flow Adequacy snapshot only -1.084
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.27 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — 0.0% — — —
FCF Payout Ratio 0.0% 0.0% — — — — — — — — — — — — 0.0% — 0.0% 0.0% — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — 0.0% — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — 0 0
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.3% -0.3% -0.4% -0.4% -0.3% -0.2% -0.2% -0.2% -0.1% -0.1% -12.3% -13.4% -18.3% -19.5% -15.8% -12.3% -5.8% -3.2% -3.1% -2.6% -2.60%
Total Shareholder Return -0.3% -0.3% -0.4% -0.4% -0.3% -0.2% -0.2% -0.2% -0.1% -0.1% -12.3% -13.4% -18.3% -19.5% -15.8% -12.3% -5.8% -3.2% -3.1% -2.3% -2.27%
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.02 1.02 1.01 1.01 0.99 0.98 0.98 0.98 0.98 0.99 0.95 0.96 -0.03 0.78 1.21 1.27 1.269
Interest Burden (EBT/EBIT) 0.95 0.97 0.97 0.99 0.99 1.01 1.04 1.07 1.10 1.07 1.05 1.04 1.06 1.08 1.71 2.05 0.39 0.75 1.56 1.58 1.581
EBIT Margin -1.08 -1.30 -0.44 -0.62 -0.72 -0.54 -0.52 -0.66 -0.78 -1.55 -12.83 -26.76 -21.37 -23.01 -0.16 -0.13 0.17 0.32 -0.26 -0.24 -0.238
Asset Turnover 0.22 0.25 0.36 0.34 0.35 0.36 0.34 0.33 0.33 0.24 0.04 0.02 0.03 0.03 0.45 0.53 0.66 0.83 0.32 0.38 0.383
Equity Multiplier 1.42 1.38 1.63 1.67 1.74 2.04 1.77 1.89 2.18 2.82 1.98 2.42 4.17 7.70 2.17 2.66 3.88 4.22 2.96 3.54 3.536
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
EPS (Diluted TTM) $-1.35 $-1.75 $-1.04 $-1.46 $-1.66 $-1.46 $-1.39 $-1.69 $-1.91 $-2.76 $-3.82 $-4.34 $-4.91 $-5.12 $-1.07 $-1.07 $-0.01 $1.44 $-2.11 $-2.23 $-2.23
Book Value/Share $3.91 $3.56 $4.19 $4.29 $3.77 $3.56 $4.13 $3.41 $2.53 $1.49 $3.92 $2.66 $1.52 $0.42 $5.08 $3.76 $3.43 $4.04 $4.31 $3.25 $3.25
Tangible Book/Share $3.78 $3.44 $4.07 $4.18 $3.66 $3.45 $4.03 $3.31 $2.43 $1.40 $3.85 $2.59 $1.45 $0.36 $5.02 $3.70 $3.38 $3.99 $4.27 $3.21 $3.21
Revenue/Share $1.32 $1.38 $2.44 $2.36 $2.30 $2.62 $2.52 $2.39 $2.24 $1.69 $0.29 $0.16 $0.22 $0.21 $4.23 $4.29 $6.11 $7.75 $4.37 $4.67 $4.67
FCF/Share $1.41 $1.18 $-0.69 $-1.13 $-1.79 $-2.23 $-3.27 $-3.20 $-3.08 $-3.75 $-3.81 $-4.28 $-4.95 $-4.58 $0.07 $-0.13 $1.16 $2.29 $-0.36 $-0.52 $-0.52
OCF/Share $1.64 $1.42 $-0.48 $-0.87 $-1.29 $-1.42 $-2.26 $-1.84 $-1.43 $-1.83 $-2.08 $-2.83 $-3.79 $-3.94 $0.45 $0.16 $1.32 $2.41 $-0.25 $-0.41 $-0.41
Cash/Share $3.52 $3.16 $3.72 $3.94 $3.56 $4.73 $4.45 $4.22 $3.76 $2.05 $4.24 $3.52 $5.58 $4.43 $8.16 $6.48 $6.77 $6.51 $12.53 $11.17 $11.17
EBITDA/Share $-1.35 $-1.72 $-0.98 $-1.38 $-1.55 $-1.32 $-1.22 $-1.47 $-1.64 $-2.50 $-3.56 $-4.09 $-4.60 $-4.65 $-0.51 $-0.38 $1.21 $2.63 $-0.94 $-0.93 $-0.93
Debt/Share $0.24 $0.24 $0.24 $0.77 $0.77 $0.77 $0.77 $0.77 $3.57 $3.65 $3.24 $3.66 $6.98 $6.98 $5.51 $5.13 $2.70 $2.22 $9.64 $6.03 $6.03
Net Debt/Share $-3.27 $-2.92 $-3.49 $-3.17 $-2.79 $-3.96 $-3.68 $-3.45 $-0.19 $1.60 $-1.00 $0.14 $1.40 $2.56 $-2.65 $-1.35 $-4.08 $-4.29 $-2.88 $-5.15 $-5.15
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 3.842
Altman Z-Prime snapshot only 8.290
Piotroski F-Score 4 4 2 3 3 4 1 2 3 2 2 1 2 2 4 5 6 6 2 4 4
Beneish M-Score 0.62 -5.52 0.21 -3.76 -3.90 104.23 47.25 5.72 -5.11 -9.28 — — -2.12 -3.54 — — 5.42 90.34 38.53 -2.13 -2.131
Ohlson O-Score snapshot only -5.386
ROIC (Greenblatt) snapshot only -8.78%
Net-Net WC snapshot only $0.18
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Credit Rating snapshot only BBB
Credit Score 81.48 82.30 74.72 75.72 74.45 64.03 58.20 63.49 39.57 30.65 40.77 28.30 23.96 22.46 35.36 34.77 69.94 84.08 52.42 56.04 56.045
Credit Grade snapshot only 9
Credit Trend snapshot only 21.273
Implied Spread (bps) snapshot only 275.000
Industry Credit Rank snapshot only 53
Sector Credit Rank snapshot only 48

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms